Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NBP	NOVABRIDGE BIOSCIENCES	$219.35M	-37.90%	-34.40%	-36.71%	-265.40%	0.15	7.64	N/A	N/A	N/A
SSII	SS INNOVATIONS INTERNATIONAL INC	$701.35M	-26.80%	-15.00%	-10.79%	-12.90%	0.82	2.24	47.60%	-23.70%	-13.40%
ALEC	ALECTOR INC	$256.81M	-531.00%	-44.00%	-69.72%	-67.00%	-21.35	5.26	100.00%	-850.10%	-847.98%
COGT	COGENT BIOSCIENCES INC	$6.29B	-72.60%	-48.70%	-47.98%	-53.60%	0.57	13.57	N/A	N/A	N/A
CING	CINGULATE INC	$82.60M	-238.40%	-128.70%	-117.27%	-1,212.90%	0.41	3.50	N/A	N/A	N/A
RXST	RXSIGHT INC	$260.37M	-17.40%	-14.70%	-17.20%	-17.30%	0.34	4.07	77.50%	-36.80%	-36.70%
RNXT	RENOVORX INC	$56.41M	-145.60%	-109.80%	-128.13%	3,950.20%	0.28	5.74	84.40%	-621.70%	-621.71%
CBUS	CIBUS INC	$132.22M	-320.60%	-30.90%	-20.45%	-21.10%	20.18	1.62	100.00%	-2,258.90%	-1,406.69%
GOVX	GEOVAX LABS INC	$5.06M	-743.70%	-394.70%	-1,058.19%	-8,300.30%	1.64	1.54	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$10.72B	N/A	-59.00%	-48.14%	-34.80%	-12.09	6.66	88.00%	-1,321.10%	-1,240.14%
TRAX	FIRST TRACKS BIOTHERAPEUTICS INC	$1.55B	N/A	N/A	N/A	N/A	0.09	14.28	N/A	N/A	N/A
MIRM	MIRUM PHARMACEUTICALS INC	$6.28B	-410.20%	-96.50%	-102.66%	-154.60%	-101.27	2.86	81.70%	-139.20%	-136.57%
AVTX	AVALO THERAPEUTICS INC	$1.03B	-58.00%	-48.20%	-21.33%	-68.70%	0.09	19.31	100.00%	-170,055.90%	-169,766.10%
ANRO	ALTO NEUROSCIENCE INC	$1.42B	-46.50%	-39.10%	-34.53%	-404.10%	0.16	14.85	N/A	N/A	N/A
TTRX	TURN THERAPEUTICS INC	$288.35M	-281.60%	-64.90%	-100.10%	-372.50%	23.69	1.19	N/A	N/A	N/A
TLSI	TRISALUS LIFE SCIENCES INC	$314.65M	N/A	-114.40%	-43.61%	-59.10%	8.53	5.35	85.80%	-130.20%	-49.61%
BJDX	BLUEJAY DIAGNOSTICS INC	$4.02M	-125.00%	-99.80%	-77.20%	-1,294.50%	0.23	4.64	N/A	N/A	N/A
IBIO	IBIO INC	$70.54M	-53.90%	-46.50%	-34.62%	-120.80%	0.11	11.88	100.00%	-9,202.00%	-9,154.33%
MDXG	MIMEDX GROUP INC	$622.40M	2.60%	2.00%	4.06%	10.20%	0.30	5.33	78.80%	1.80%	2.77%
GENB	GENERATE BIOMEDICINES INC	$2.27B	N/A	N/A	N/A	N/A	0.23	8.30	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$115.25M	-171.20%	-66.10%	-123.30%	583.90%	2.04	3.48	N/A	N/A	N/A
RDY	DR REDDYS LABORATORIES LTD	$10.20B	12.10%	8.00%	14.31%	18.40%	0.53	1.80	52.80%	12.80%	17.54%
QURE	UNIQURE NV	$3.29B	-112.00%	-29.00%	-20.57%	-19.90%	2.04	10.01	92.50%	-1,350.70%	-993.35%
MOH	MOLINA HEALTHCARE INC	$10.36B	-0.20%	0.00%	2.44%	3.80%	2.84	1.68	8.00%	0.00%	0.46%
QTRX	QUANTERIX CORP	$132.42M	-43.60%	-31.80%	-46.54%	-69.40%	0.35	3.40	42.70%	-80.20%	-81.68%
CDT	CDT EQUITY INC	$1.96M	-72.30%	-55.40%	-35.79%	-72.40%	0.23	0.13	N/A	N/A	N/A
VSTM	VERASTEM INC	$621.27M	-467.50%	-94.50%	-156.10%	-369.60%	3.13	2.26	86.40%	-231.60%	-228.97%
IPSC	CENTURY THERAPEUTICS INC	$383.88M	-52.80%	-40.60%	-40.40%	-54.50%	0.24	8.28	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$285.41M	-57.60%	-46.50%	-59.44%	-56.60%	0.28	10.89	100.00%	-3,537.70%	-3,520.25%
PLSE	PULSE BIOSCIENCES INC	$3.50B	-94.40%	-80.00%	-76.55%	-987.10%	0.16	9.63	0.30%	-6,755.80%	-6,755.78%
EWTX	EDGEWISE THERAPEUTICS INC	$4.86B	-39.00%	-37.00%	-43.76%	-43.00%	0.07	16.24	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$87.29M	-161.60%	-118.40%	-160.16%	1,956.40%	0.37	4.36	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$148.26M	N/A	-288.00%	2,502.35%	43,243.80%	-3.52	0.81	195.60%	5,253.50%	5,364.40%
ICCM	ICECURE MEDICAL LTD	$6.14M	-174.30%	-112.60%	-140.33%	-1,210.30%	0.49	2.88	36.10%	-427.70%	-423.69%
AQST	AQUESTIVE THERAPEUTICS INC	$602.46M	N/A	-52.40%	-53.54%	-44.30%	-3.34	7.19	67.00%	-144.60%	-114.45%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$2.62B	N/A	N/A	N/A	N/A	1.47	1.42	N/A	N/A	N/A
ENTA	ENANTA PHARMACEUTICALS INC	$410.67M	-61.80%	-20.70%	-20.69%	-18.00%	1.94	3.76	100.00%	-96.90%	-76.95%
NVAX	NOVAVAX INC	$1.46B	N/A	-22.80%	-35.75%	-36.00%	-6.01	2.33	78.60%	-59.90%	-53.99%
AGMB	AGOMAB THERAPEUTICS NV	$624.81M	N/A	N/A	N/A	N/A	0.10	12.88	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$132.72M	-143.10%	-109.20%	-85.35%	825.20%	0.15	7.86	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$93.67M	-50.20%	-40.20%	-50.12%	1,019.40%	0.18	7.03	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$982.18M	-72.30%	-61.40%	-52.85%	-114.30%	0.12	13.82	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$589.47M	-188.30%	-59.10%	-86.45%	-58.20%	5.26	3.06	100.00%	-4,613.10%	-4,613.11%
BIVI	BIOVIE INC	$16.14M	-126.30%	-109.10%	-210.96%	-2,942.30%	0.39	3.59	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$119.38M	-1,625.90%	-101.30%	-159.50%	-130.10%	-50.24	3.15	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$94.28M	-70.10%	-61.60%	-84.69%	-103.80%	0.14	7.99	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$3.19B	-52.40%	-47.60%	-41.68%	-58.10%	0.10	11.82	100.00%	-190,220.90%	-190,220.89%
ABCL	ABCELLERA BIOLOGICS INC	$3.25B	-17.50%	-12.40%	-15.97%	-16.80%	0.46	12.77	100.00%	-248.80%	-302.80%
CTMX	CYTOMX THERAPEUTICS INC	$716.89M	-39.90%	-31.50%	-23.27%	-39.50%	0.26	9.36	100.00%	-451.60%	-433.95%
AKTS	AKTIS ONCOLOGY INC	$1.44B	N/A	N/A	N/A	N/A	0.15	16.33	N/A	N/A	N/A
MDAI	SPECTRAL AI INC	$51.50M	N/A	-54.60%	2,019.40%	379.00%	-2.61	0.90	42.90%	-65.50%	-56.81%
OCGN	OCUGEN INC	$461.19M	N/A	-116.00%	826.79%	-333.10%	-8.50	0.80	100.00%	-1,786.30%	-1,601.94%
SYRE	SPYRE THERAPEUTICS INC	$9.40B	-24.30%	-22.20%	-16.12%	-28.00%	0.07	18.53	N/A	N/A	N/A
CDXS	CODEXIS INC	$181.78M	-74.40%	-23.60%	-26.07%	-17.70%	2.64	3.06	87.00%	-39.60%	-32.41%
ALDX	ALDEYRA THERAPEUTICS INC	$91.70M	-53.10%	-34.90%	-57.10%	452.20%	0.26	4.91	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$275.67M	-71.10%	-30.90%	-38.23%	-224.90%	0.76	6.61	99.50%	-246.60%	-286.94%
EIKN	EIKON THERAPEUTICS INC	$604.48M	N/A	N/A	N/A	N/A	0.67	9.89	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$149.37M	N/A	-126.90%	-7,809.79%	89.60%	-201.94	0.86	46.60%	-691.80%	-658.10%
AARD	AARDVARK THERAPEUTICS INC	$150.57M	-71.50%	-64.90%	-93.09%	-163.90%	0.09	12.63	N/A	N/A	N/A
SXTC	CHINA SXT PHARMACEUTICALS INC	$45.51k	-27.50%	-22.00%	-20.20%	-668.40%	0.17	7.94	2,169,246.30%	-15,134,353.70%	-14,980,780.49%
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$141.37M	N/A	-141.50%	-257.14%	-1,223.30%	-2.38	2.00	48.30%	-2,955.60%	-2,949.76%
DTIL	PRECISION BIOSCIENCES INC	$233.23M	-91.60%	-40.70%	-43.28%	-144.40%	1.78	12.82	100.00%	-117.00%	-114.11%
SMMT	SUMMIT THERAPEUTICS INC	$10.16B	-168.90%	-141.90%	-131.99%	-296.20%	0.19	6.96	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$592.15M	-147.20%	-103.20%	-98.22%	3,983.00%	1.68	8.98	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$747.47M	-13.10%	-12.80%	-13.63%	-28.40%	0.03	33.56	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$407.59M	-46.50%	-36.50%	-48.90%	-375.40%	0.31	5.88	100.00%	-317.60%	-317.64%
ERAS	ERASCA INC	$6.16B	-80.40%	-67.10%	-71.54%	-74.30%	0.20	8.29	N/A	N/A	N/A
CRVO	CERVOMED INC	$39.76M	-156.00%	-128.30%	-132.18%	-408.30%	0.13	8.57	100.00%	-9,160.90%	-9,160.94%
PLRX	PLIANT THERAPEUTICS INC	$70.59M	-53.20%	-41.30%	-52.68%	-46.40%	0.29	9.90	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$5.28M	-118.10%	-59.70%	-57.22%	-304.60%	1.19	1.36	31.10%	-523.00%	-471.21%
CLDI	CALIDI BIOTHERAPEUTICS INC	$3.57M	-500.50%	-236.40%	-436.10%	-1,006.70%	1.30	1.68	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$24.02M	-618.90%	-100.70%	-802.91%	538.50%	7.35	1.48	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$1.40B	-53.10%	-48.30%	-63.34%	-67.30%	0.13	8.42	N/A	N/A	N/A
MNKD	MANNKIND CORP	$1.31B	N/A	-6.30%	-0.03%	0.00%	-11.90	1.72	75.40%	-11.10%	-0.05%
GLUE	MONTE ROSA THERAPEUTICS INC	$1.18B	-43.30%	-27.60%	-25.97%	-40.30%	0.42	10.58	100.00%	-560.90%	-570.80%
DMAC	DIAMEDICA THERAPEUTICS INC	$351.60M	-77.80%	-69.50%	-97.80%	-90.80%	0.17	6.72	N/A	N/A	N/A
ACTU	ACTUATE THERAPEUTICS INC	$29.54M	-346.20%	-178.40%	-1,465.67%	470.00%	4.26	1.25	N/A	N/A	N/A
NMAD	NOMAD POWER SOLUTIONS INC	$66.82M	-75.10%	-62.70%	-34.30%	-113.60%	0.07	12.87	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$3.17M	-519.10%	-194.60%	-246.52%	388.90%	0.29	3.00	N/A	N/A	N/A
NNOX	NANO-X IMAGING LTD	$60.14M	-51.90%	-45.50%	-59.78%	-150.10%	0.15	3.64	-84.90%	-523.80%	-542.14%
BTAI	BIOXCEL THERAPEUTICS INC	$23.82M	N/A	-185.80%	49.50%	-110.00%	-1.25	0.21	53.10%	-9,549.90%	-7,228.57%
RCUS	ARCUS BIOSCIENCES INC	$3.84B	-89.50%	-45.60%	-61.85%	-65.40%	0.99	3.82	100.00%	-393.20%	-383.76%
TECX	TECTONIC THERAPEUTIC INC	$712.97M	-35.30%	-33.60%	-37.68%	-22,463.10%	0.06	22.29	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$213.53M	-69.00%	-61.30%	-71.50%	-367.40%	0.14	6.61	83.80%	-548.60%	-548.64%
AHCO	ADAPTHEALTH CORP	$767.62M	-15.20%	-5.20%	-3.83%	-4.70%	2.14	1.12	17.00%	-7.10%	-4.31%
ERNA	ERNEXA THERAPEUTICS INC	$8.22M	-306.30%	-170.10%	-362.58%	1,161.00%	0.97	2.01	N/A	N/A	N/A
BOLD	BOUNDLESS BIO INC	$67.33M	-70.90%	-47.40%	-97.02%	-44.60%	0.12	9.48	N/A	N/A	N/A
IMTX	IMMATICS NV	$1.19B	-47.00%	-39.20%	-48.22%	-112.80%	0.22	7.54	100.00%	-495.30%	-495.79%
CVRX	CVRX INC	$83.92M	-152.40%	-50.90%	-56.61%	-64.80%	3.63	8.05	86.90%	-84.90%	-75.09%
QSI	QUANTUM-SI INC	$168.32M	-47.10%	-43.20%	-54.29%	-52.70%	0.07	9.97	35.00%	-6,138.30%	-6,144.17%
ZBIO	ZENAS BIOPHARMA INC	$2.06B	-189.70%	-89.90%	-72.33%	-118.20%	1.84	9.93	100.00%	-48,438.40%	-45,990.40%
ENLV	ENLIVEX LTD	$23.90M	248.10%	206.40%	69.81%	279.90%	0.20	193.24	N/A	N/A	N/A
AVLN	AVALYN PHARMA INC	$1.67B	N/A	N/A	N/A	N/A	0.07	33.12	N/A	N/A	N/A
MDXH	MDXHEALTH SA	$3.81M	N/A	-25.10%	-12.76%	-8.40%	-5.34	1.15	63.70%	-33.50%	-10.83%
FLNA	FILANA THERAPEUTICS INC	$44.93M	-58.80%	-36.70%	-66.33%	204.70%	0.63	2.09	N/A	N/A	N/A
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	$5.05M	N/A	-443.70%	-166.77%	-29,672.30%	0.15	7.70	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$0.00	-147.40%	-74.70%	-128.95%	259.70%	1.08	0.60	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$441.93M	-64.20%	-57.10%	-84.14%	-96.80%	0.14	8.13	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$973.65M	-38.40%	-34.70%	-17.36%	-1,845.60%	0.05	25.13	N/A	N/A	N/A
KRRO	KORRO BIO INC	$192.46M	-114.30%	-68.60%	-70.15%	-69.50%	0.58	9.55	100.00%	-4,477.10%	-4,441.86%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	613	-0.66%	+1.64%	+7.19%	-17.98%	18.56x	5.57x	-15.13%	-10.95%	-8.57%	+46.54%	Strong Buy
Diagnostics & Research	50	-0.34%	+3.55%	+10.09%	+23.82%	14.40x	4.48x	-25.43%	+5.42%	+11.81%	+0.98%	Buy
Drug Manufacturers - General	20	-0.08%	+5.31%	+6.39%	+49.25%	40.91x	8.31x	+25.85%	+10.89%	+19.30%	+4.98%	Buy
Drug Manufacturers - Specialty & Generic	75	+0.18%	+0.39%	-1.16%	-93.84%	2.74x	1.67x	+2.45%	+3.59%	+20.64%	+40.41%	Strong Buy
Healthcare Plans	10	+1.15%	+1.07%	-1.15%	+22.84%	52.50x	2.37x	+10.84%	+3.32%	+8.21%	+10.47%	Buy
Health Information Services	50	-0.41%	+4.15%	+20.60%	-37.95%	10.43x	3.87x	+6.24%	+3.17%	+8.22%	+15.34%	Buy
Medical Care Facilities	48	-0.30%	+1.85%	+3.39%	+7.12%	17.17x	5.62x	-40.58%	+6.94%	+13.63%	+10.69%	Buy
Medical Devices	133	-0.80%	+0.62%	+9.31%	-99.46%	24.64x	3.37x	-4.67%	+5.19%	+9.51%	+21.95%	Strong Buy
Medical Distribution	9	+1.63%	+1.42%	+3.44%	+27.84%	25.42x	-176.85x	-71.67%	+4.08%	+24.10%	+13.05%	Buy
Medical Instruments & Supplies	52	-0.44%	+2.13%	+13.77%	+5.01%	44.70x	3.35x	+7.77%	+6.59%	+10.29%	+12.67%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bristol Myers Squibb Co (NYSE:BMY)

Bristol Myers Squibb Co (NYSE:BMY) is the #1 top healthcare stock out of 1060 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bristol Myers Squibb Co (NYSE:BMY) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Bristol Myers Squibb Co (NYSE:BMY) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 18 out of 38 due diligence checks and has strong fundamentals. Bristol Myers Squibb Co has seen its stock return 42.72% over the past year, overperforming other healthcare stocks by 138 percentage points.

Bristol Myers Squibb Co has an average 1 year price target of $67.40, an upside of 0.18% from Bristol Myers Squibb Co's current stock price of $67.28.

Bristol Myers Squibb Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Bristol Myers Squibb Co, 54.55% have issued a Strong Buy rating, 0% have issued a Buy, 45.45% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #2 top healthcare stock out of 1060 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 52, which is 26 points higher than the healthcare sector average of 26. It passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 82.77% over the past year, overperforming other healthcare stocks by 178 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -34.21% from Puma Biotechnology's current stock price of $9.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1060 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 49, which is 23 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 99.46% over the past year, overperforming other healthcare stocks by 195 percentage points.

Electromed has an average 1 year price target of $40.00, a downside of -0.72% from Electromed's current stock price of $40.29.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 78 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 38.27%, which is 36 percentage points higher than the healthcare sector average of 2.62%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 20.41%, which is 18 percentage points higher than the healthcare sector average of 2.62%.

Siga Technologies's dividend payout ratio of -1,500% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.75%, which is 9 percentage points higher than the healthcare sector average of 2.62%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.34% in the last day, and up 2.19% over the last week. Regenxbio was the among the top losers in the healthcare sector, dropping -24.86% yesterday.

REGENXBIO shares are trading lower after the company announced that the FDA placed a clinical hold on RGX-121 following the discovery of asymptomatic spine MRI findings in five participants in the CAMPSIITE study

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 71, which is 57 points higher than the healthcare sector average of 14. It passed 5 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 225.2% in the past year. It has overperformed other stocks in the healthcare sector by 320 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 43 points higher than the healthcare sector average of 14. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.89% in the past year. It has overperformed other stocks in the healthcare sector by 98 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 29, which is 15 points higher than the healthcare sector average of 14. It passed 2 out of 7 valuation due diligence checks.

Exelixis's stock has gained 43.93% in the past year. It has overperformed other stocks in the healthcare sector by 139 percentage points.

Are healthcare stocks a good buy now?

61.34% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 24.13% over the next year.

4.84% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.15% of healthcare stocks are rated B (Buy), 46.28% are rated C (Hold), 28.29% are rated D (Sell), and 7.44% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 31.74x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bristol Myers Squibb Co (NYSE:BMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Electromed (NYSEMKT:ELMD)

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

2. Siga Technologies (NASDAQ:SIGA)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bristol Myers Squibb Co (NYSE:BMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Electromed (NYSEMKT:ELMD)

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

2. Siga Technologies (NASDAQ:SIGA)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.